UBS Group’s CRH Medical Corporation CRHM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-60,537
| Closed | -$239K | – | 10372 |
|
|
2021
Q1 | $239K | Buy |
60,537
+59,037
| +3,936% | +$191K | ﹤0.01% | 5358 |
|
|
2020
Q4 | $4K | Hold |
1,500
| – | – | ﹤0.01% | 7965 |
|
|
2020
Q3 | $3K | Sell |
1,500
-926
| -38% | -$2.16K | ﹤0.01% | 7606 |
|
|
2020
Q2 | $5K | Buy |
2,426
+926
| +62% | +$1.87K | ﹤0.01% | 7411 |
|
|
2020
Q1 | $2K | Sell |
1,500
-1,720
| -53% | -$5.62K | ﹤0.01% | 7685 |
|
|
2019
Q4 | $11K | Sell |
3,220
-179,851
| -98% | -$568K | ﹤0.01% | 7262 |
|
|
2019
Q3 | $564K | Sell |
183,071
-1,977
| -1% | -$5.87K | ﹤0.01% | 4463 |
|
|
2019
Q2 | $561K | Buy |
185,048
+181,969
| +5,910% | +$521K | ﹤0.01% | 4208 |
|
|
2019
Q1 | $8K | Sell |
3,079
-22,755
| -88% | -$70.2K | ﹤0.01% | 6975 |
|
|
2018
Q4 | $79K | Sell |
25,834
-2,248
| -8% | -$7.41K | ﹤0.01% | 5743 |
|
|
2018
Q3 | $111K | Sell |
28,082
-179,952
| -87% | -$663K | ﹤0.01% | 5514 |
|
|
2018
Q2 | $645K | Buy |
208,034
+3,034
| +1% | +$9.68K | ﹤0.01% | 4129 |
|
|
2018
Q1 | $523K | Buy |
205,000
+180,000
| +720% | +$505K | ﹤0.01% | 4167 |
|
|
2017
Q4 | $66K | Buy |
25,000
+13,000
| +108% | +$29K | ﹤0.01% | 5643 |
|
|
2017
Q3 | $31K | Buy |
12,000
+4,947
| +70% | +$15.2K | ﹤0.01% | 6145 |
|
|
2017
Q2 | $41K | Buy |
7,053
+1,083
| +18% | +$7.03K | ﹤0.01% | 5805 |
|
|
2017
Q1 | $49K | Buy |
5,970
+4,824
| +421% | +$33.4K | ﹤0.01% | 5540 |
|
|
2016
Q4 | $6K | Sell |
1,146
-5,167
| -82% | -$26.2K | ﹤0.01% | 7180 |
|
|
2016
Q3 | $24K | Buy |
+6,313
| New | +$24.1K | ﹤0.01% | 6166 |
|
|
2016
Q2 | – | Sell |
-9,673
| Closed | -$32K | – | 8086 |
|
|
2016
Q1 | $32K | Buy |
9,673
+2,873
| +42% | +$8.23K | ﹤0.01% | 5841 |
|
|
2015
Q4 | $20K | Buy |
6,800
+4,900
| +258% | +$13.6K | ﹤0.01% | 6772 |
|
|
2015
Q3 | $6K | Buy |
+1,900
| New | +$6.88K | ﹤0.01% | 7632 |
|
UBS Group's CRHM Position: Q2 2021 in Review
UBS Group sold out of CRH Medical Corporation (CRHM) in Q2 2021, closing a stake of 60,537 shares — an estimated $239K sold.
UBS Group first reported a position in CRHM in Q3 2015 and held it in 22 quarters. The position peaked at $645K in Q2 2018. 1 fund tracked by Wall St. Rank holds CRHM as of Q2 2021.
- UBS Group reported no remaining CRH Medical Corporation position as of Q2 2021 after selling out during the quarter.
- UBS Group sold 60,537 CRH Medical Corporation shares in Q2 2021, an estimated $239K.
- UBS Group first reported a position in CRH Medical Corporation in Q3 2015 and held it in 22 quarters.
- UBS Group's CRH Medical Corporation position peaked at $645K in Q2 2018.
- 1 fund tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2021.
Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.